Blockbuster retatrutide trial signals a ‘new high-water mark’ for
weight-loss drugs
-
The experimental weight-loss drug is a triple agonist and the first of its
kind to reach a phase 3 clinical trial
14 hours ago
No comments:
Post a Comment